Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The trial is a phase II study of daily Tarceva combined with definitive radiotherapy in
inoperable locally advanced non small cell lung cancer (stage IIB-IIIB). The objective of the
phase II trial is to examine Tarceva concomitant with curatively intended irradiation 66 Gy
(2 Gy x 33 F, 5 F per week).
Phase:
Phase 2
Details
Lead Sponsor:
Olfred Hansen
Collaborators:
Aalborg Universitetshospital Aalborg University Hospital Aarhus University Hospital Copenhagen University Hospital at Herlev Naestved Hospital Odense University Hospital Rigshospitalet, Denmark